Why the study?
To provide clinical considerations for competitive sports participation among athletes with cardiovascular abnormalities or diseases regarding potential risks of adverse cardiovascular events.
This AHA/ACC scientific statement provides expert consensus and clinical considerations for competitive sports participation in athletes with cardiovascular abnormalities, emphasizing shared decision-making.
Informs shared decision-making for athletes with CV abnormalities; leaves open need for prospective outcome data.
No abstract was published with this document — society guidelines, consensus pathways, and scientific statements are typically released without one. See the Key Points and the linked PDF for the full content.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: